公司简介

宏聲醫療科技(香港)有限公司

Currently worldwide, intravitreal injection is the most common treatment for a wide range of retinal diseases. It is a horrifying, painful process that could induce a series of side effects. For most patients, they have to endure monthly, or even weekly injections to effectively treat their disease. Developed by Sonikure Technology aiming to replace needle injections, the Sonikure device safely and efficiently deliver drugs into the eye via our patented low energy and low intensity ultrasonic technology. Compatible to commercial viable eye drugs, the treatment is non-invasive, painless, and proven complication-free in pre-clinical trials.

Unit 208C, 2/F, Enterprise Place No. 5 Science Park West Avenue Hong Kong Sicence Park, Pak Shek Kok,HK
+852 2520 0220
Ms. Sarah Cheung
联系我们

如有一般咨询,或有关香港科技园服务与援助计划的问题,请在下方空白处填写您的电子邮箱和咨询内容。